Ikonisys SA (ALIKO)

Currency in EUR
1.52
0.00(0.00%)
Closed·
ALIKO Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
ALIKO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.521.52
52 wk Range
1.281.71
Key Statistics
Prev. Close
1.52
Open
1.52
Day's Range
1.52-1.52
52 wk Range
1.28-1.71
Volume
-
Average Volume (3m)
2.81K
1-Year Change
3.4%
Book Value / Share
1.5
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALIKO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2.80
Upside
+84.21%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Ikonisys SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Ikonisys SA Company Profile

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of gene rearrangements commonly associated with non-small cell lung carcinoma; oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene, which is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. In addition, it offers liquid biopsy/CTC bladder cancer detection and breast cancer early diagnostics products; CYTOfast vial solution for any type of cellular analysis; CYTOfast kit urine, a three day cytological urine test solution; CYTOfast PLUS, a liquid-phase processor that prepares thin-layer cytological samples from liquid-phase specimen; and Ikonisys intelligent application, a software designed to automatically quantify, qualify, and present cells for review. Ikonisys S.A. was incorporated in 2021 and is headquartered in Paris, France.

Compare ALIKO to Peers and Sector

Metrics to compare
ALIKO
Peers
Sector
Relationship
P/E Ratio
−7.9x−2.0x−0.5x
PEG Ratio
-−0.030.00
Price/Book
1.3x1.2x2.6x
Price / LTM Sales
45.2x1.0x3.3x
Upside (Analyst Target)
84.2%119.4%43.5%
Fair Value Upside
Unlock2.0%6.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.80
(+84.21% Upside)

Earnings

Latest Release
Nov 07, 2024
EPS / Forecast
-0.13 / --
Revenue / Forecast
297.54K / --
EPS Revisions
Last 90 days

ALIKO Income Statement

FAQ

What Stock Exchange Does Ikonisys Trade On?

Ikonisys is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Ikonisys?

The stock symbol for Ikonisys is "ALIKO."

What Is the Ikonisys Market Cap?

As of today, Ikonisys market cap is 21.32M.

What Is Ikonisys's Earnings Per Share (TTM)?

The Ikonisys EPS (TTM) is -0.26.

From a Technical Analysis Perspective, Is ALIKO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Ikonisys Stock Split?

Ikonisys has split 0 times.

How Many Employees Does Ikonisys Have?

Ikonisys has 10 employees.

What is the current trading status of Ikonisys (ALIKO)?

As of 09 Aug 2025, Ikonisys (ALIKO) is trading at a price of 1.52, with a previous close of 1.52. The stock has fluctuated within a day range of 1.52 to 1.52, while its 52-week range spans from 1.28 to 1.71.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.